China NMPA Drug Inspection - Yunnan Suimin Biotechnology Development Co., Ltd. - Honeysuckle
China NMPA drug inspection for Yunnan Suimin Biotechnology Development Co., Ltd. published November 09, 2018. Drug: Honeysuckle. The Guizhou Provincial Food and Drug Administration issued its third Drug Sampling Information Announcement of 2018 on N
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Yunnan Suimin Biotechnology Development Co., Ltd. published November 09, 2018. Drug: Honeysuckle. The Guizhou Provincial Food and Drug Administration issued its third Drug Sampling Information Announcement of 2018 on N
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox